Eli Lilly And Stock Performance

LLY Stock  USD 1,040  23.24  2.19%   
On a scale of 0 to 100, Eli Lilly holds a performance score of 17. The firm shows a Beta (market volatility) of 0.0637, which means not very significant fluctuations relative to the market. As returns on the market increase, Eli Lilly's returns are expected to increase less than the market. However, during the bear market, the loss of holding Eli Lilly is expected to be smaller as well. Please check Eli Lilly's treynor ratio, as well as the relationship between the expected short fall and day median price , to make a quick decision on whether Eli Lilly's price patterns will revert.

Risk-Adjusted Performance

Solid

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak essential indicators, Eli Lilly showed solid returns over the last few months and may actually be approaching a breakup point. ...more
 
Eli Lilly dividend paid on 10th of December 2025
12/10/2025
Begin Period Cash Flow2.8 B
Total Cashflows From Investing Activities-9.3 B

Eli Lilly Relative Risk vs. Return Landscape

If you would invest  81,234  in Eli Lilly and on October 29, 2025 and sell it today you would earn a total of  22,323  from holding Eli Lilly and or generate 27.48% return on investment over 90 days. Eli Lilly and is generating 0.4169% of daily returns assuming volatility of 1.9215% on return distribution over 90 days investment horizon. In other words, 17% of stocks are less volatile than Eli, and above 92% of all equities are expected to generate higher returns over the next 90 days.
  Expected Return   
       Risk  
Considering the 90-day investment horizon Eli Lilly is expected to generate 2.56 times more return on investment than the market. However, the company is 2.56 times more volatile than its market benchmark. It trades about 0.22 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.07 per unit of risk.

Eli Lilly Target Price Odds to finish over Current Price

The tendency of Eli Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 1,040 90 days 1,040 
about 43.53
Based on a normal probability distribution, the odds of Eli Lilly to move above the current price in 90 days from now is about 43.53 (This Eli Lilly and probability density function shows the probability of Eli Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon Eli Lilly has a beta of 0.0637. This indicates as returns on the market go up, Eli Lilly average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Eli Lilly and will be expected to be much smaller as well. Additionally Eli Lilly and has an alpha of 0.4025, implying that it can generate a 0.4 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Eli Lilly Price Density   
       Price  

Predictive Modules for Eli Lilly

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Eli Lilly. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
1,0381,0401,041
Details
Intrinsic
Valuation
LowRealHigh
935.561,1601,162
Details
Naive
Forecast
LowNextHigh
1,0291,0311,033
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
1,0331,0691,105
Details

Eli Lilly Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Eli Lilly is not an exception. The market had few large corrections towards the Eli Lilly's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Eli Lilly and, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Eli Lilly within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.40
β
Beta against Dow Jones0.06
σ
Overall volatility
64.95
Ir
Information ratio 0.18

Eli Lilly Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Eli Lilly for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Eli Lilly can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Over 83.0% of the company shares are owned by institutional investors
On 10th of December 2025 Eli Lilly paid $ 1.5 per share dividend to its current shareholders

Eli Lilly Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Eli Stock often depends not only on the future outlook of the current and potential Eli Lilly's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Eli Lilly's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding904.1 M
Cash And Short Term Investments3.4 B

Eli Lilly Fundamentals Growth

Eli Stock prices reflect investors' perceptions of the future prospects and financial health of Eli Lilly, and Eli Lilly fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Eli Stock performance.

About Eli Lilly Performance

Evaluating Eli Lilly's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Eli Lilly has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Eli Lilly has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana. Eli Lilly operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. It employs 35000 people.

Things to note about Eli Lilly performance evaluation

Checking the ongoing alerts about Eli Lilly for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Eli Lilly help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Over 83.0% of the company shares are owned by institutional investors
On 10th of December 2025 Eli Lilly paid $ 1.5 per share dividend to its current shareholders
Evaluating Eli Lilly's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Eli Lilly's stock performance include:
  • Analyzing Eli Lilly's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Eli Lilly's stock is overvalued or undervalued compared to its peers.
  • Examining Eli Lilly's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Eli Lilly's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Eli Lilly's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Eli Lilly's stock. These opinions can provide insight into Eli Lilly's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Eli Lilly's stock performance is not an exact science, and many factors can impact Eli Lilly's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Additional Tools for Eli Stock Analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.